Device type · DDR
Myoglobin, Antigen, Antiserum, Control
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
DDR
Immunology
Device class
Class II
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
8
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Myoglobin, Antigen, Antiserum, Control
- Product code
- DDR
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5680
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DDR
Latest FDA decisions
- Access Myoglobin510(k)
K231832 · Decided Sep 18, 2023 · 88 days after receipt
Device type: Myoglobin, Antigen, Antiserum, Control (DDR) · Laboratory Medicine & Pathology
Reports received
8
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
8
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 1 | 0 | 0 | 0 |
| Mar 24 | 19 | 0 | 0 | 0 |
| Apr 24 | 4 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 3 | 0 | 0 | 0 |
| Jul 24 | 3 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 2 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 1 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 1 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 2 | 0 | 0 | 0 |
| Mar 26 | 1 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 1 | 0 | 0 | 0 |
| Jun 26 | 2 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 1 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
The full in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Low Test Results5
The full in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions8
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- ARCHITECT STAT Myoglobin Reagent Kit, LN 2K43-25 and 2K43-20.Open, Classified
Z-1476-2024 · Started Feb 21, 2024 · Posted by FDA Apr 4, 2024
Reason given: The reason for the recall is the failure of calibration and quality controls due to a manufacturing issue of microparticles not meeting labeled claim. This may lead to incorrect myoglobin results and delayed diagnosis of myocardial infarction.
Cause as FDA categorized it: Nonconforming Material/Component
11 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.